Riverhead Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $696K | Hold |
4,905
| – | – | 0.03% | 590 |
|
|
2019
Q2 | $614K | Hold |
4,905
| – | – | 0.02% | 649 |
|
|
2019
Q1 | $540K | Hold |
4,905
| – | – | 0.02% | 679 |
|
|
2018
Q4 | $481K | Buy |
4,905
+100
| +2% | +$9.81K | 0.02% | 672 |
|
|
2018
Q3 | $593K | Buy |
4,805
+900
| +23% | +$111K | 0.02% | 672 |
|
|
2018
Q2 | $388K | Hold |
3,905
| – | – | 0.02% | 776 |
|
|
2018
Q1 | $345K | Hold |
3,905
| – | – | 0.01% | 814 |
|
|
2017
Q4 | $385K | Buy |
3,905
+600
| +18% | +$59.2K | 0.02% | 772 |
|
|
2017
Q3 | $318K | Buy |
3,305
+475
| +17% | +$45.7K | 0.01% | 781 |
|
|
2017
Q2 | $268K | Buy |
2,830
+1,130
| +66% | +$107K | 0.01% | 804 |
|
|
2017
Q1 | $139K | Buy |
1,700
+200
| +13% | +$16.4K | 0.01% | 875 |
|
|
2016
Q4 | $127K | Sell |
1,500
-230
| -13% | -$19.5K | 0.01% | 885 |
|
|
2016
Q3 | $129K | Sell |
1,730
-77,800
| -98% | -$5.8M | 0.01% | 809 |
|
|
2016
Q2 | $6.06M | Buy |
79,530
+66,755
| +523% | +$5.08M | 0.19% | 158 |
|
|
2016
Q1 | $886K | Sell |
12,775
-1,825
| -13% | -$127K | 0.01% | 694 |
|
|
2015
Q4 | $879K | Buy |
14,600
+11,100
| +317% | +$668K | 0.01% | 683 |
|
|
2015
Q3 | $189K | Buy |
+3,500
| New | +$189K | ﹤0.01% | 723 |
|